Transaction · 0001193125-26-438722
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
Mahboob Vaseem
Mahboob Vaseem, CFO, reported a transaction classified as exercise at KESTRA MEDICAL TECHNOLOGIES, LTD. involving 34809.000000 shares for an estimated $591753.00. Reported holdings after the transaction were 95418.000000 shares. The stored filing text includes a detected 10b5-1 reference.
exerciseSEC transaction code MCFO
- Trade date
- Oct 27, 2026
- Filing date
- Oct 29, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
KMTS price since this filing
Daily closing prices, with the filing date and available return windowsKMTS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -11.3%1w ago -7.6%1d ago -3.9%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-438722 Common Shares
- Transaction date
- Oct 27, 2026 Filed Oct 29, 2026, 10:46 PM · 2d delay
- Shares
- 34,809 sh $17.00 per share
- Estimated value
- $591k Computed from shares × price
- Holdings after
- 95,418 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase 10b5-1 Detected
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief Financial Officer
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025.
- F2
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.0000 to $30.4300. Upon request, the reporting person will provide to the Issuer…
- F3
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.0100 to $30.9800. Upon request, the reporting person will provide to the Issuer…
- F4
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.3500 to $31.0400. Upon request, the reporting person will provide to the Issuer…
- F5
Includes 91,066 fully vested options as of the transaction date, with the remaining 33,125 options vesting in equal monthly installments through March 6, 2027.
- F6
Includes 51,163 fully vested options as of the transaction date, with the remaining 33,125 options vesting in equal monthly installments through March 6, 2027.
- F7
Includes 46,375 fully vested options as of the filing date, with the remaining 33,125 options vesting in equal monthly installments through March 6, 2027.
Related transactions
Same SEC filing0 other transactions
Recent company activity
KMTS0 recent txs